stockrowTrulieve Cannabis Corp.
TRLV Healthcare Drug Manufacturers Specialty & Generic
Trulieve Cannabis Corp.’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, roughly unchanged from fiscal 2024.
- Revenue
- −20.1%
- EPS
- −2,391.1%
- Free cash flow
- +24.5%
- Total debt
- −37.0%
Quarter to September 2026, against a year earlier
Follow TRLV
Alert me
Trulieve Cannabis Corp. (TRLV) Revenue growth
Trulieve Cannabis Corp.'s revenue growth over the twelve months to 30 September 2026 was −9.09%, down 8.6 percentage points from fiscal 2025 (−0.45%). Over the past ten years it has ranged from −7.31% (fiscal 2023) to 78.7% (fiscal 2021); the current reading is higher than 40% of that period. That is below the Drug Manufacturers Specialty & Generic industry median of 5.22% and below the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | −0.45% | (5.52) |
| FY2024 | 5.07% | 12.38 |
| FY2023 | −7.31% | (38.03) |
| FY2022 | 30.7% | (47.97) |
| FY2021 | 78.7% | — |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | −20.1% | (9.81) |
| Jun 2026 | −10.3% | (6.61) |
| Mar 2026 | −3.70% | (1.04) |
| Dec 2025 | −2.66% | (4.03) |
| 15 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| ALVO Alvotech compare | 364.3% |
| HCM HUTCHMED (China) Limited Sponsored ADR compare | 245.2% |
| BCRX BioCryst Pharmaceuticals, Inc. compare | 60.3% |
| XERS Xeris Biopharma Holdings, Inc. compare | 38.4% |
| ANIP ANI Pharmaceuticals, Inc. compare | 25.9% |
| PBH Prestige Consumer Healthcare Inc. compare | 5.10% |
| PRGO Perrigo Company plc compare | −4.47% |
| TRLV Trulieve Cannabis Corp. | −9.09% |
| RGC Regencell Bioscience Holdings Limited compare | — |
| Drug Manufacturers Specialty & Generic industry median | 5.22% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on TRLV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement